Yes Maxter, likewise I thought PTX was undervalued at pre consolidation levels and was my first entry point but I have averaged down since changing some long term positions in other stocks which I don't like doing. I am normally wary of biotechs and although I cannot get my head around their clinical trials I feel the board have the experience and the strategy to increase the MC subject to one of their clinical trials proving successful. So it is a high risk punt for a high return and hopefully any future dilutions are managed correctly.
PTX Price at posting:
7.1¢ Sentiment: Buy Disclosure: Held
